Mass screening programmes and trends in cervical cancer in Finland and the Netherlands
Corresponding Author
Maaike A. van der Aa
Comprehensive Cancer Centre, Stedendriehoek Twente, Enschede, The Netherlands
Fax: +31-53-4306295.
Comprehensive Cancer Centre, Stedendriehoek Twente, Hoedemakerplein 2, 7511 JP EnschedeSearch for more papers by this authorEero Pukkala
Finnish Cancer Registry, Institute for Statistical and Epidemiological Cancer Research, Helsinki, Finland
Search for more papers by this authorJan Willem W. Coebergh
Department of Public Health, Erasmus Medical Centre, Rotterdam, The Netherlands
Eindhoven Cancer Registry, Comprehensive Cancer Centre South, Eindhoven, The Netherlands
Search for more papers by this authorAhti Anttila
Finnish Cancer Registry, Institute for Statistical and Epidemiological Cancer Research, Helsinki, Finland
Search for more papers by this authorSabine Siesling
Comprehensive Cancer Centre, Stedendriehoek Twente, Enschede, The Netherlands
Search for more papers by this authorCorresponding Author
Maaike A. van der Aa
Comprehensive Cancer Centre, Stedendriehoek Twente, Enschede, The Netherlands
Fax: +31-53-4306295.
Comprehensive Cancer Centre, Stedendriehoek Twente, Hoedemakerplein 2, 7511 JP EnschedeSearch for more papers by this authorEero Pukkala
Finnish Cancer Registry, Institute for Statistical and Epidemiological Cancer Research, Helsinki, Finland
Search for more papers by this authorJan Willem W. Coebergh
Department of Public Health, Erasmus Medical Centre, Rotterdam, The Netherlands
Eindhoven Cancer Registry, Comprehensive Cancer Centre South, Eindhoven, The Netherlands
Search for more papers by this authorAhti Anttila
Finnish Cancer Registry, Institute for Statistical and Epidemiological Cancer Research, Helsinki, Finland
Search for more papers by this authorSabine Siesling
Comprehensive Cancer Centre, Stedendriehoek Twente, Enschede, The Netherlands
Search for more papers by this authorAbstract
With respect to cervical cancer management, Finland and the Netherlands are comparable in relevant characteristics, e.g., fertility rate, age-of-mother at first birth and a national screening programme for several years. The aim of this study is to compare trends in incidence of and mortality from cervical cancer in Finland and the Netherlands in relation to the introduction and intensity of the screening programmes. Therefore, incidence and mortality rates were calculated using the Cancer Registries of Finland and the Netherlands. Data on screening intensity were obtained from the Finnish Cancer Registry and the Dutch evaluation centre at ErasmusMC-Rotterdam. Women aged 30–60 have been screened every 5 years, in Finland since 1992 and in the Netherlands since 1996. Screening protocols for smear taking and referral to the gynaecologist are comparable. Incidence and mortality rates have declined more in Finland. In 2003, age-adjusted incidence and mortality in Finland were 4.0 and 0.9 and in the Netherlands 4.9 and 1.4 per 100,000 woman-years, respectively. Excess smear use in the Netherlands was estimated to be 24 per 1,000 women during a 5-year interval compared to 121 in Finland. The decline in mortality in Finland seems to be almost completely related to the screening programme whereas in the Netherlands it was initially considered to be a natural decline. Differences in risk factors might also play a role: the Netherlands has higher population density and higher percentages of immigrants and (female) smokers. The greater excess smear use in Finland might also have affected incidence. © 2007 Wiley-Liss, Inc.
References
- 1 Gustafsson L,Ponten J,Zack M,Adami HO. International incidence rates of invasive cervical cancer after introduction of cytological screening. Cancer Causes Control 1997; 8: 755–63.
- 2 van Ballegooijen M,van den Akker-van M,Patnick J,Lynge E,Arbyn M,Anttila A,Ronco G,Dik J,Habbema F. Overview of important cervical cancer screening process values in European Union (EU) countries, and tentative predictions of the corresponding effectiveness and cost-effectiveness. Eur J Cancer 2000; 36: 2177–88.
- 3 Anttila A,Ronco G,Clifford G,Bray F,Hakama M,Arbyn M,Weiderpass E. Cervical cancer screening programmes and policies in 18 European countries. Br J Cancer 2004; 91: 935–41.
- 4 International Agency for Research on Cancer. Handbook of cancer prevention.Cervix cancer screening. Lyon: IARC, 2005.
- 5 Hakama M,Rasanen-Virtanen U. Effect of a mass screening program on the risk of cervical cancer. Am J Epidemiol 1976; 103: 512–7.
- 6 Peto J,Gilham C,Fletcher O,Matthews FE. The cervical cancer epidemic that screening has prevented in the UK. Lancet 2004; 364: 249–56.
- 7 Raffle AG. Deaths from cervical cancer began falling before screening programmes were established. BMJ 1997; 315: 953–4.
- 8 Monsonego J,Bosch FX,Coursaget P,Cox JT,Franco E,Frazer I,Sankaranarayanan R,Schiller J,Singer A,Wright TC,Jr,Kinney W,Meijer CJ, et al. Cervical cancer control, priorities and new directions. Int J Cancer 2004; 108: 329–33.
- 9 Quint WG,ter Harmsel WA,van Doorn LJ. Vaccination against human papillomavirus for the prevention of cervical cancer. Ned Tijdschr Geneeskd 2006; 150: 1380–4.
- 10 Berkhof J,de Bruijne MC,Zielinski GD,Bulkmans NW,Rozendaal L,Snijders PJ,Verheijen RH,Meijer CJ. Evaluation of cervical screening strategies with adjunct high-risk human papillomavirus testing for women with borderline or mild dyskaryosis. Int J Cancer 2006; 118: 1759–68.
- 11 Bulkmans NW,Bulk S,Ottevanger MS,Rozendaal L,Hellenberg SM,van Kemenade FJ,Snijders PJ,Boeke AJ,Meijer CJ. Implementation of human papillomavirus testing in cervical screening without a concomitant decrease in participation rate. J Clin Pathol 2006; 59: 1218–20.
- 12 French KM,Barnabas RV,Lehtinen M,Kontula O,Pukkala E,Dillner J,Garnett GP. Strategies for the introduction of human papillomavirus vaccination: modelling the optimum age- and sex-specific pattern of vaccination in Finland. Br J Cancer 2007; 96: 514–8.
- 13 Cuzick J,Mayrand MH,Ronco G,Snijders P,Wardle J. Chapter 10: New dimensions in cervical cancer screening. Vaccine 2006; 24 ( Suppl 3): S90–S97.
- 14 Anttila A,Hakama M,Kotaniemi-Talonen L,Nieminen P. Alternative technologies in cervical cancer screening: a randomised evaluation trial. BMC Public Health 2006; 6: 252.
- 15 de Sanjose S,Bosch FX,Munoz N,Shah K. Social differences in sexual behaviour and cervical cancer. IARC Sci Publ 1997; 309–17.
- 16 Franco EL,Duarte-Franco E,Ferenczy A. Cervical cancer: epidemiology, prevention and the role of human papillomavirus infection. CMAJ 2001; 164: 1017–25.
- 17 Levi F,Lucchini F,Negri E,Franceschi S,la Vecchia C. Cervical cancer mortality in young women in Europe: patterns and trends. Eur J Cancer 2000; 36: 2266–71.
- 18 WHO—European health. Available at: http://www.euro.who.int/hfadb. 2006.
- 19 United Nations Economic Commission for Europe: Statistical Database. Available at: http://www.unece.org/stats/data.htm. 2007.
- 20 Visser O,Coebergh JWW,Dijck van JAAM,Siesling S. Incidence of cancer in the Netherlands 1998. Utrecht: Vereniging van Integrale Kankercentra, 2002.
- 21 Statistics Netherlands (CBS). Available at: http://statline.cbs.nl/StatWeb. 2005.
- 22 Finnish Cancer Registry. Available at: http://www.cancerregistry.fi/atlasweb/index.htm. 2007.
- 23 Anttila A,Nieminen P. Cervical cancer screening programme in Finland. Eur J Cancer 2000; 36: 2209–14.
- 24 van der Graaf Y,Peer PG,Zielhuis GA,Vooijs PG. Cervical cancer survival in Nijmegen region, The Netherlands, 1970–1985. Gynecol Oncol 1988; 30: 51–6.
- 25 Bulk S,Visser O,Rozendaal L,Verheijen RH,Meijer CJ. Incidence and survival rate of women with cervical cancer in the Greater Amsterdam area. Br J Cancer 2003; 89: 834–9.
- 26 van Ballegooijen M,Hermens R. Cervical cancer screening in the Netherlands. Eur J Cancer 2000; 36: 2244–6.
- 27 Papanicolaou GN. New cancer diagnosis. Proceedings of Third Race Betterment Conference. Michigan, USA 1928. 528–34.
- 28 Solomon D,Davey D,Kurman R,Moriarty A,O'Connor D,Prey M,Raab S,Sherman M,Wilbur D,Wright T,Jr,Young N. The 2001 Bethesda system: terminology for reporting results of cervical cytology. JAMA 2002; 287: 2114–9.
- 29 Rebolj M,van BM,Berkers LM,Habbema D. Monitoring a national cancer prevention program: successful changes in cervical cancer screening in the Netherlands. Int J Cancer 2007; 120: 806–12.
- 30 Koopmanschap MA,van Oortmarssen GJ,van Agt HM,van Ballegooijen M,Habbema JD,Lubbe KT. Cervical-cancer screening: attendance and cost-effectiveness. Int J Cancer 1990; 45: 410–5.
- 31 Bulk S,Visser O,Rozendaal L,Verheijen RH,Meijer CJ. Cervical cancer in the Netherlands 1989–1998: Decrease of squamous cell carcinoma in older women, increase of adenocarcinoma in younger women. Int J Cancer 2005; 113: 1005–9.
- 32 Hakama M,Louhivuori K. A screening programme for cervical cancer that worked. Cancer Surv 1988; 7: 403–16.
- 33 Hristova L,Hakama M. Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017. Acta Oncol 1997; 36 ( Suppl 9): 1–60.
- 34
Anttila A,Pukkala E,Soderman B,Kallio M,Nieminen P,Hakama M.
Effect of organised screening on cervical cancer incidence and mortality in Finland, 1963–1995: recent increase in cervical cancer incidence.
Int J Cancer
1999;
83:
59–65.
10.1002/(SICI)1097-0215(19990924)83:1<59::AID-IJC12>3.0.CO;2-N CAS PubMed Web of Science® Google Scholar
- 35 Bielska-Lasota M,Inghelmann R,van de Poll-Franse LV,Capocaccia R. Trends in cervical cancer survival in Europe, 1983–1994: a population-based study. Gynecol Oncol 2007; 105: 609–19.
- 36 van der Graaf Y,Zielhuis GA,Vooijs GP. Cervical cancer mortality in the Netherlands. Int J Epidemiol 1988; 17: 270–6.
- 37 International Agency for Research on Cancer, Globocan. Available at: http://www-dep.iarc.fr/. 2007.
- 38 Visser O,van Leeuwen FE. Cancer risk in first generation migrants in North-Holland/Flevoland, The Netherlands, 1995–2004. Eur J Cancer 2007; 43: 901–8.
- 39 Signaleringscommissie Kanker van KWF Kankerbestrijding. Allochtonen en kanker. Oisterwijk: Drukkerij van den Boogaard, 2006.
- 40 Comprehensive Cancer Centres. Available at: http://www.ikcnet.nl/. 2007.
- 41Eurosurveillance. Available at: http://www.eurosurveillance.org. 2007.
- 42 European Medicines Agency. Available at: http://emea.europa.eu. 2007.
- 43 Luoto R,Raitanen J,Pukkala E,Anttila A. Effect of hysterectomy on incidence trends of endometrial and cervical cancer in Finland 1953–2010. Br J Cancer 2004; 90: 1756–9.
- 44 Brolmann HA,Vervest HA,Heineman MJ. Declining trend in major gynaecological surgery in The Netherlands during 1991–1998. Is there an impact on surgical skills and innovative ability? BJOG 2001; 108: 743–8.
- 45 Rogstad KE. The psychological impact of abnormal cytology and colposcopy. BJOG 2002; 109: 364–8.
- 46 van Ballegooijen M,Koopmanschap MA,van Oortmarssen GJ,Habbema JD,Lubbe KT,van Agt HM. Diagnostic and treatment procedures induced by cervical cancer screening. Eur J Cancer 1990; 26: 941–5.